Mónica Andrea Morales García

Dr. Mónica Andrea Morales García

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2024 in The Korean Journal of Orthodontics
Verified
Journal Article
Open access
PDF file
DBDiego López Buitrago
Diego López Buitrago
DODavid Acosta Olmos
David Acosta Olmos
MGMónica Andrea Morales García
Mónica Andrea Morales García
Diego Fernando López, David Acosta Olmos, Mónica Andrea Morales. Korean J Orthod 2024;54:239-46. https://doi.org/10.4041/kjod24.017

14 January 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
VJVanessa Bedoya Joaqui
Vanessa Bedoya Joaqui
NGNathalia Buitrago Gómez
Nathalia Buitrago Gómez
ROReinaldo Carvajal Ortiz
Reinaldo Carvajal Ortiz
LTLuis Miguel Osorio Toro
Luis Miguel Osorio Toro
Jenny Patricia Muñoz-LomboJenny Patricia Muñoz-Lombo
Jenny Patricia Muñoz-Lombo
AAAlin Abreu-Lomba
Alin Abreu-Lomba
Objectives:To evaluate the effectiveness of adding dapagliflozin as an intensification strategy for the treatment of patients with uncontrolled type 2 diabetes mellitus (T2DM). Materials and methods: A historical cohort study was conducted in 123 adult patients over 18 years old who were diagnosed with uncontrolledT2DM, who received dapagliflozin add-on to their dual base treatment: metformin plus glibenclamide (n = 32), metformin plus saxagliptin (n = 29), metformin plus exenatide (n = 28), or metformin plus insulin (n = 34).The endpoints were evaluated using analysis of variance. All the patients completed a 52-week follow-up. Overall, 52.85% of patients were female, the Hispanic population represented the largest proportion of patients in all groups (60.98%), and the mean +/- SD patient age and body weight were 55.05 +/- 7.58 years and 83.55 +/- 9.65 kg, respectively. The mean +/- SD duration ofT2DM, glycated hemoglobin (Hbk(1c)), and fasting plasma glucose (FPG) were 5.93 +/- 2.98 years, 8.1 +/- 0.53%, and 166.03 +/- 26.80 mg/dL, respectively. The grand mean changes of HbA(1c), FPG, body weight and blood pressure showed a decreasing trend during the study period and it was statistically significant in all groups (p-value = <0.001). The proportion of patients achieving HbA(1c) target (<7%) was highest in the group that used a dapagliflozin add-on to metformin plus saxagliptin. Conclusion . The addition of dapagliflozin as an alternative for intensification of dual therapy consistently improved, not only FPG and HbA(1c), but also body weight and blood pressure, with statistically significant results.

28 December 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
ALAlin Abreu Lomba
Alin Abreu Lomba
MTMaria Elena Tello-Cajiao
Maria Elena Tello-Cajiao
MGMónica Andrea Morales García
Mónica Andrea Morales García
AMAlexander Martínez
Alexander Martínez
MMMauricio Andrés Salazar Moreno
Mauricio Andrés Salazar Moreno
Juan S. Izquierdo-CondoyJuan S. Izquierdo-Condoy
Juan S. Izquierdo-Condoy
Background: Thyroid eye disease (TED), or Graves’ orbitopathy, is the most common extra-thyroidal manifestation of Graves’ disease, but it has only rarely been reported after SARS-CoV-2 vaccination. Autoimmune thyroid disease, including subacute thyroiditis and Graves’ disease, has been described following COVID-19 vaccination; we present a case series of TED occurring shortly after different COVID-19 vaccines to provide clinical data on this potential safety signal. Case presentation: We describe five women (mean age 47 years; range 27–69) who developed TED 3–20 days after COVID-19 vaccination with mRNA or adenoviral vector vaccines, three of whom had pre-existing thyroid disease. Presentations included ocular and retro-orbital pain, exophthalmos, headache, goiter, tremor, depressive symptoms, and, in one case, anterior neck pain and fever. TED severity (ETA/EUGOGO) ranged from mild to severe, with frequent findings of suppressed TSH, elevated thyroid autoantibodies, and inflammatory markers, as well as imaging evidence of exophthalmos, extraocular muscle enlargement, and diffuse or multinodular goiter. Management with intravenous corticosteroids, selenium, levothyroxine adjustment, and/or intramuscular corticosteroids led to improvement in thyroid function and inflammation by 3 months, although mild TED often persisted. Conclusions: This case series supports a temporal association between COVID-19 vaccination and new-onset or exacerbated TED in individuals with autoimmune thyroid disease. Although vaccination benefits outweigh potential risks, clinicians should remain alert to ocular and thyroid symptoms after immunization to ensure timely diagnosis and management.

18 April 2022 in Revista de la Facultad de Medicina
Verified
Journal Article
Open access
PDF file
CBCarmen Elisa Ocampo Benavides
Carmen Elisa Ocampo Benavides
MGMónica Andrea Morales García
Mónica Andrea Morales García
MCMartín Cañón-Muñoz
Martín Cañón-Muñoz
CPChristian Pallares-Gutierrez
Christian Pallares-Gutierrez
KLKaren Daniela López
Karen Daniela López
AFAdrián Fernández-Osorio
Adrián Fernández-Osorio
Introducción. Actualmente, hay pocos estudios en Latinoamérica sobre las características demográficas, clínicas y de laboratorio de pacientes con COVID-19 y con requerimiento de ingreso a unidad de cuidados intensivos (UCI). Objetivo. Comparar las características sociodemográficas, clínicas, imagenológicas y de laboratorio de pacientes diagnosticados con COVID-19 atendidos en el servicio de urgencias de una clínica en Cali, Colombia, según requerimiento de ingreso a UCI. Materiales y métodos. Estudio retrospectivo descriptivo de cohorte única realizado en 49 adultos con COVID-19 atendidos en el servicio de urgencias de un hospital de cuarto nivel de atención en Cali, Colombia, en marzo y abril de 2020, los cuales se dividieron en dos grupos: requerimiento de UCI (n=24) y no requerimiento de UCI (n=25). Se realizaron análisis bivariados para determinar las diferencias entre ambos grupos (pruebas de chi-2, exacta de Fisher, t de Student y U de Mann-Whitney), con un nivel de significancia de p<0.05. Resultados. La edad promedio fue 53 años (DE=13) y 29 pacientes fueron hombres. Se encontraron diferencias significativas entre ambos grupos en las siguientes variables: edad promedio (UCI x̅=58 vs. No UCI x̅=49; p=0.020), presencia de diabetes (8 vs. 1; p=0.010), presencia de dificultad respiratoria (20 vs. 11; p=0.007), presencia uni o bilateral de áreas de consolidación (12 vs. 3; p=0.005), mediana del conteo de leucocitos (Med=7570/mm3 vs. Med=5130/mm3; p=0.0013), de neutrófilos (Med=5980/mm3 vs. Med=3450/mm3; p=0,0001) y linfocitos (Med=865/mm3 vs. Med=1400/mm3; p<0,0001), mediana de proteína C reactiva (Med=141,25mg/L vs. Med=27,95mg/L; p<0,001), ferritina (Med=1038ng/L vs. Med=542,5ng/L; p=0.0073) y lactato-deshidrogenasa (Med=391U/L vs, Med=248,5U/L, p=0,0014). Finalmente, 15 pacientes requirieron ventilación mecánica invasiva, 2 presentaron extubación fallida, y en total, 5 fallecieron. Conclusiones. Se observaron diferencias significativas en los valores de varios marcadores inflamatorios, daño celular y parámetros del hemograma entre los pacientes que requirieron admisión a la UCI y los que no, por lo que estas variables podrían emplearse para desarrollar herramientas que contribuyan a establecer el pronóstico de esta enfermedad.